Theseus Pharmaceuticals, Inc.
THRX · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $95 | $245 | $8 | $1 |
| Short-Term Investments | $103 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4 | $3 | $0 | $0 |
| Total Curr. Assets | $198 | $248 | $9 | $1 |
| Property Plant & Equip (Net) | $5 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $14 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $6 | $3 | $0 | $0 |
| Total NC Assets | $24 | $3 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $222 | $251 | $9 | $1 |
| Liabilities | – | – | – | – |
| Payables | $5 | $1 | $1 | $0 |
| Short-Term Debt | $1 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $5 | $3 | $0 | $0 |
| Total Curr. Liab. | $11 | $4 | $2 | $1 |
| LT Debt | $3 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $1 | $41 | $10 |
| Total NC Liab. | $4 | $1 | $41 | $10 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $15 | $4 | $43 | $11 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $251 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$112 | -$62 | -$34 | -$10 |
| AOCI | -$0 | -$251 | $0 | $1 |
| Other Equity | $320 | $308 | $0 | -$6 |
| Total Equity | $208 | $246 | -$34 | -$9 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $222 | $251 | $9 | $1 |
| Net Debt | -$91 | -$245 | -$8 | -$1 |